DARE BIOSCIENCE, INC. (DARE)
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
Atlassian (DX) Named a Leader in the 2026 Gartner® Magic Quadrant™ for Developer Productivity Insight Platforms
KANZHUN LIMITED Announces Results of Annual General Meeting
Xometry Launches Foundation, Committing $1 Million to Advance Engineering Education, Community Impact and U.S. Workforce Development Programs
Validation Institute Confirms Alight Healthcare Navigation Delivers Measurable Savings
Trustee report to holders of BONDS 6 for the year 2025, Mishmeret
Trustee report to BONDS 5 holders for 2025, Mishmeret
Starwood Property Trust Announces Private Offering of Sustainability Bonds
Milestone Scientific Strengthens Board to Support Next Phase of Growth
Trustee report to the holders of BONDS 4 for 2025, Mishmeret